RBC
DXCM icon

Roble Belko & Company’s DexCom DXCM Stock Holding History

Roble Belko & Company’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
19
– – ﹤0.01% 418
2026
Q1 		$1K Hold
19
– – ﹤0.01% 416
2025
Q4 		$1K Hold
19
– – ﹤0.01% 418
2025
Q3 		$1K Hold
19
– – ﹤0.01% 383
2025
Q2 		$2K Hold
19
– – ﹤0.01% 334
2025
Q1 		$1K Hold
19
– – ﹤0.01% 350
2024
Q4 		$1K Hold
19
– – ﹤0.01% 327
2024
Q3 		$1K Hold
19
– – ﹤0.01% 305
2024
Q2 		$2K Hold
19
– – ﹤0.01% 285
2024
Q1 		$3K Hold
19
– – ﹤0.01% 277
2023
Q4 		$2K Buy
19
+9
+90% +$919 ﹤0.01% 284
2023
Q3 		$1K Hold
10
– – ﹤0.01% 267
2023
Q2 		$1K Buy
+10
New +$1.21K ﹤0.01% 270

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Roble Belko & Company's DXCM Position: Q2 2026 in Review

Roble Belko & Company held its DexCom (DXCM) position steady in Q2 2026 at 19 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

Roble Belko & Company first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $3K in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Roble Belko & Company held 19 shares of DexCom worth $1K as of Q2 2026.
  • Roble Belko & Company left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #418 holding.
  • Roble Belko & Company first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • Roble Belko & Company's DexCom position peaked at $3K in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.